Poultry Diagnostics Market Analysis & Forecast: 2025-2032

Poultry Diagnostics Market Analysis & Forecast

Poultry Diagnostics Market is estimated to be valued at USD 666.4 Mn in 2025 and is expected to reach USD 1,418.8 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 11.4% from 2025 to 2032.

Key Takeaways

• By Test Type, the segment on PCR (Polymerase Chain Reaction) is estimated to dominate the poultry diagnostics market outlook in 2025 with a share of nearly 54% due to its sensitivity, accuracy, and rapid adoption for disease detection.
• By Region, North America is expected to be the most dominant holder of the global poultry diagnostics market with an estimated 32.1% share by 2025 because of its developed veterinary infrastructure and animal health investment surveillance.

Market Overview

The Global Poultry Diagnostics Market is encountering challenges such as increasing recalls of products by regulatory organizations like the U.S. Food and Drug Administration, which may restrict growth in the market. Nevertheless, the adoption of organics strategies such as product innovations by key players is likely to drive the expansion of the market in the upcoming forecast period.

Current Events and Its Impact on the Global Poultry Diagnostics Market

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Pipeline Analysis

The poultry diagnostics pipeline is focused on advancing innovative avian influenza diagnostic methods, Newcastle disease testing, and comprehensive poultry disease testing solutions. Unlike pharmaceuticals, diagnostic tools undergo analytical validation (accuracy, precision, specificity), followed by clinical validation through field testing in poultry populations, and then regulatory approval from agencies like USDA or FDA-CVM.

Molecular diagnostics still dominate the pipeline. New multiplex PCR/qPCR panels for simultaneous detection of various strains of avian influenza, Newcastle disease virus, and even some Salmonella pathogens are being developed. These panels are meant to provide precise case detection critical for outbreak control. With the increasing demand for portable and quick diagnostics, point-of-care and rapid test technologies such as lateral flow immunoassays and PCR systems are being developed. Even newer biosensor technologies aim to provide easier and non-invasive methods of detection. Furthermore, digital and AI-enhanced poultry diagnostics are more common due to their automated monitoring and early disease detection capabilities, using computer vision and predictive health analytics. Market leaders such as IDEXX, Zoetis, and Thermo Fisher have industry reports, regulatory databases, and company disclosures that shed light on these advancements.

Patent Landscape

An active innovation ecosystem exists in poultry diagnostics, with over 240 patents issued worldwide by 2025. This activity has centered around ELISA tests for poultry, poultry health monitoring systems, as well as farm-specific precision diagnostic instruments aimed at improving disease detection and management on poultry farms. Notable players such as IDEXX, Zoetis, Boehringer Ingelheim, and Thermo Fisher Scientific hold a significant share of these patents, particularly in molecular immunodiagnostics and immunoassays. Patent applications emanate from North America and Europe, with a spike from the Asia-Pacific region indicating a rise in demand for low-cost and rapid poultry disease diagnostics.

Research directed towards ELISA and its applications focuses on enhanced sensitivity, turnaround time, and the ability to detect multiple pathogens at once. Moreover, the patents dealing with poultry health monitoring systems aim at disease surveillance on farms via real-time embedded and connected biosensors, IoT, and AI analytics. Newer diagnostic devices focus on portability and simplicity of use to help small and medium scale poultry farmers. The ever-evolving patent landscape is suggestive of efforts to enable reliable, novel diagnostics for avian influenza and Newcastle disease. Industry stakeholders are advised to take advantage of changing technologies and market strategies through timely intervention in the space.

Reimbursement Scenario

The global reimbursement landscape for poultry diagnostics is shaped by a mix of government subsidies, agricultural insurance programs, and regional regulatory frameworks. Unlike human healthcare, reimbursement in poultry diagnostics primarily operates through agricultural insurance schemes and government-supported disease control programs.

In the United States, USDA programs such as the National Poultry Improvement Plan (NPIP) and Livestock Gross Margin Insurance (LGM-Poultry) cover approximately 75% of approved diagnostic costs, with federal subsidies reducing premiums by up to 50%. Typical reimbursed tests include avian influenza diagnostic methods, Newcastle disease testing, and Salmonella screening, with costs ranging from $25 to $85 per test.

In the European Union, under the Common Agricultural Policy (CAP), animal health measures allocate nearly €1.9 billion (2021–2027) toward diagnostic reimbursements. Coverage varies from 50% for routine monitoring to 100% for notifiable diseases, encouraging widespread adoption of diagnostic tools for poultry farms.

In the Asia-Pacific, reimbursement remains limited, with governments and regional bodies like ASEAN promoting harmonized standards but less formal insurance coverage. Subsidized diagnostic testing is often linked to outbreak control programs.

Overall, reimbursement mechanisms are evolving, with increasing recognition of poultry health monitoring systems as essential investments for sustainable poultry production and disease prevention.

Prescribers’ Preference

In the poultry diagnostics and treatment market, prescribers prioritize rapid, accurate diagnostic tools alongside effective, cost-efficient therapeutics to manage common diseases like bacterial infections, viral outbreaks, and parasitic infestations. Diagnostic methods such as PCR and ELISA are preferred for their reliability in detecting diseases like avian influenza and Newcastle disease, enabling timely intervention.

For bacterial infections, fluoroquinolones (e.g., enrofloxacin) and broad-spectrum antibiotics such as amoxicillin remain first-line treatments, balancing efficacy with regulatory withdrawal periods. Viral diseases are primarily managed through vaccination protocols—with live attenuated vaccines favored for Newcastle disease and combination vaccines gaining preference for multi-pathogen protection.

Alongside emphasizing preventative medicine, prescribers support vaccination programs, feed additives, and prophylactic supplements such as ionophores for coccidiosis management. Integrated health management systems are becoming more popular due to growing concerns regarding antimicrobial resistance, such as poultry health monitoring systems and early diagnostic screening to minimize antibiotic use. In general, an increasing number of veterinary practitioners are using sophisticated diagnostic systems and customized therapy plans to maintain optimal poultry health, adhere to stringent food safety standards, and fulfill consumer expectations for antibiotic-free poultry.

Segmental Insights

To learn more about this report, Request sample copy

Poultry Diagnostics Market Insights, By Test Type

The PCR (Polymerase Chain Reaction) segment is projected to dominate the global poultry diagnostics market by 2025, holding a market share of 54.o%. This strong position is driven by the rising demand for highly accurate and rapid detection of avian diseases.

PCR tests offer superior sensitivity and specificity, making them ideal for early diagnosis and effective disease control in poultry populations. Increasing outbreaks of avian influenza and other infectious diseases have prompted commercial poultry producers and veterinary institutions to prioritize PCR-based testing as a primary surveillance tool.

While PCR leads the segment, the market is also witnessing a surge in the launch of ELISA (Enzyme-Linked Immunosorbent Assay) tests, particularly in North America, due to their cost-effectiveness and ease of use for large-scale screening. This growing portfolio of diagnostic options continues to fuel the overall expansion of the test type segment.

Poultry Diagnostics Market Insights, By Disease Type

The Avian Salmonellosis segment is expected to command the largest share within the disease type category over the forecast period. This is primarily due to the increasing prevalence of Salmonella infections in poultry, which not only impact bird health but also pose a serious food safety concern for humans. The focus on reducing zoonotic transmission and complying with international food safety standards has led to the widespread adoption of diagnostic tests targeted at early detection of Salmonella strains.

Other major contributors in this category include Avian Influenza and Newcastle Disease, both of which have high morbidity and mortality rates, thereby driving the need for reliable, rapid diagnostics.

Poultry Diagnostics Market Insights, By End User

Among end users, the Veterinary Hospitals segment is forecast to lead the market over the coming years. The dominance of this segment can be attributed to the increasing number of veterinary hospitals, especially in developed regions, offering specialized diagnostic services. These facilities are better equipped with advanced diagnostic technologies and trained personnel capable of handling large-scale disease outbreaks.

Veterinary clinics and diagnostic centers are also playing a key role, but hospitals continue to hold the edge due to their broader service scope, infrastructure, and integration with poultry producers.

Global Poultry Diagnostics Market – Regional Insights

To learn more about this report, Request sample copy

North America Poultry Diagnostics Market Analysis and Trends

North America is set to maintain a leading position in the global poultry diagnostics market, accounting for an estimated 32.10% market share in 2025. The region benefits from a well-established veterinary healthcare infrastructure and a high level of awareness regarding poultry disease management. The United States, in particular, hosts several key players in animal diagnostics and biotechnology, fostering continuous innovation and product development.

A major driver in the region is the increasing launch and adoption of PCR (Polymerase Chain Reaction) test kits, which offer rapid, accurate, and early detection of avian diseases. These diagnostics are essential in controlling outbreaks and minimizing losses in commercial poultry farming. Additionally, stringent regulations regarding food safety and animal health have accelerated the demand for advanced diagnostics tools, making North America a dominant force in the global market.

Asia Pacific Poultry Diagnostics Market Analysis and Trends

Asia Pacific is emerging as the fastest-growing regional market for poultry diagnostics, fueled by the rising consumption of poultry products and the rapid expansion of commercial poultry farming across countries like China, India, and Indonesia. Urbanization, increasing disposable incomes, and growing awareness about animal health are contributing to greater adoption of diagnostic testing across the region.

Governments in countries such as China and India are investing heavily in modernizing agricultural and livestock practices, including disease surveillance and control measures. Additionally, the presence of cost-effective manufacturing hubs and the local production of diagnostic kits have made the region highly competitive. This trend is expected to continue, making Asia Pacific a critical engine for growth in the global poultry diagnostics market.

Dominating Countries in the Poultry Diagnostics Market

United States Poultry Diagnostics Market Analysis and Trends

The United States continues to dominate the North American poultry diagnostics market due to its highly industrialized poultry sector and strong focus on biosecurity. The country has seen a significant rise in the deployment of advanced diagnostic technologies, including real-time PCR, ELISA, and rapid test kits. Partnerships between diagnostic companies and commercial poultry producers help ensure faster response to outbreaks, enhancing overall disease management.

China Poultry Diagnostics Market Analysis and Trends

China plays a pivotal role in Asia Pacific’s poultry diagnostics landscape. With one of the world's largest poultry populations, the country faces ongoing challenges related to avian influenza and other infectious diseases. In response, China has ramped up efforts in early disease detection and veterinary testing infrastructure. Domestic companies are increasingly developing affordable diagnostic kits that meet global standards, further boosting local adoption and export potential.

India Poultry Diagnostics Market Analysis and Trends

India is witnessing steady growth in its poultry diagnostics market, supported by government-backed initiatives to modernize the livestock and poultry sectors. The growing number of poultry farms, coupled with rising concerns about zoonotic diseases, is increasing the demand for accurate and timely diagnostics. Low-cost manufacturing, combined with an expanding base of diagnostic laboratories, positions India as both a key consumer and supplier in the global poultry diagnostics ecosystem.

Market Report Scope

Global Poultry Diagnostics Market – Drivers

• Increasing adoption of inorganic growth strategies such as product launches by key market players

Increasing adoption of inorganic growth strategies such as product launches by key market players is expected to drive the global poultry diagnostics market growth over the forecast period. For instance, in April 2022, BIOMERIEUX, a biotechnology company, announced that they had launched GENE-UP QUANT Salmonella, true non-enrichment quantification diagnostic for Salmonella.

The exact quantification and fast turnaround time of the new test allows poultry producers to evaluate and improve operational processes and mitigation measures, while reducing antimicrobial use, cost and waste.

Global Poultry Diagnostics Market Cross Sectional Analysis

In type segment, PCR test holds a dominant segment due to the increasing usage PCR test. For instance, in December 2020, a study was conducted to compare and evaluate the effect PCR test for poultry diagnostics test. The PCR test and into ELISA (Enzyme-Linked Immunosorbent Assay were operated in two different modes after PCR test had shown more positive effect for diagnostics purpose.

Global Poultry Diagnostics Market: Restraint

• Lack of awareness of poultry diseases is expected to hinder the global poultry diagnostics market over the forecast period. For instance, in August 2020, according to the data published in frontiers journal, emergence of poultry diseases due to improper nutrition and unsuitable environment affects the development and structure of the poultry farming.

Analyst Viewpoint

• The market is witnessing strong growth driven by rising global demand for poultry meat and eggs, along with increasing concerns over biosecurity in commercial poultry farming.
• Frequent outbreaks of avian diseases such as highly pathogenic avian influenza and Newcastle disease are accelerating the adoption of advanced diagnostics for early detection and containment.
• A notable shift is occurring from reactive treatment to preventive diagnostics, fueled by consumer demand for antibiotic-free poultry products.
• Technological innovations in molecular diagnostics—particularly PCR and point-of-care devices—are enhancing testing speed, sensitivity, and on-site applicability.
• Despite technological progress, high equipment costs and lack of skilled personnel in emerging markets remain key barriers to broader adoption.
• Regulatory dynamics are dual-edged: stricter food safety laws are spurring demand, while prolonged approval timelines continue to delay new product introductions.
• The Asia-Pacific region is leading the market due to intensive poultry farming practices in China, India, and Southeast Asia, where disease outbreaks have high economic impact.
• Integration of digital tools and AI into diagnostic platforms is emerging as a major trend, offering predictive analytics and real-time disease monitoring.
• Proactive disease management via diagnostics is increasingly viewed as a strategic investment for long-term productivity and sustainability in poultry production.

Global Poultry Diagnostics Market: Key Developments

• In February 2025, IDEXX Laboratories launched a new multiplex PCR panel designed for the simultaneous detection of Newcastle Disease Virus (NDV), Avian Influenza (AI), and Infectious Bronchitis Virus (IBV), aimed at enhancing diagnostic efficiency in commercial poultry farms.
• In August 2024, BioChek and Bio-X both entered into a strategic partnership agreement to combine the strength of both the companies in Animal Health Diagnostics.
• In July 2024, Boehringer Ingelheim launched a next-generation ELISA test kit for Infectious Bursal Disease (IBD), offering improved sensitivity and reduced assay time to support faster outbreak control.
• In March 2024, Merck Animal Health entered into a strategic research collaboration with Aviagen to co-develop advanced diagnostic solutions for early detection of emerging poultry pathogens, including novel avian respiratory viruses.

Market Segmentation

• Global Poultry Diagnostics Market, By Test Type
  • ELISA (Enzyme-Linked Immunosorbent Assay)
  • PCR (Polymerase Chain Reaction)
  • Others (Direct Agglutination Test, etc.)
• Global Poultry Diagnostics Market, By Disease Type
  • Avian Salmonellosis
  • Avian Influenza
  • Newcastle Disease
  • Infectious Bronchitis
  • Infectious Bursal Disease
  • Others (Chicken Anemia, Avian Mycoplasmosis, etc.)
•  Global Poultry Diagnostics Market, By End User
  • Veterinary Hospitals
  • Veterinary Clinics
  • Veterinary Diagnostic Centers
•  Global Poultry Diagnostics Market, By Region
  • North America
    
    • U.S.
    • Canada
  • Latin America
    
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    
    • South Africa
    • Central Africa
    • North Africa
• Company Profiles
  • Zoetis
  • Thermo Fisher Scientific Inc.
  • Baltivet
  • Bioingentech
  • Devex
  • BioChek
  • QIAGEN
  • Bioneer Corporation
  • Megacor Diagnostik GmbH
  • Merck & Co., Inc.
  • IdentiGEN
  • Abaxis
  • BIOMERIEUX
  • Transasia Bio-Medicals
  • Boehringer Ingelheim International GmbH
  • EW Group Ltd.
  • Hygiena, LLC.

Sources

Primary Research Interviews

• Poultry Diagnostics Equipment Manufacturers
• Veterinary Diagnostic Laboratories
• Poultry Farm Owners and Operators
• Veterinary Practitioners and Specialists
• Others

Databases

• FAO (Food and Agriculture Organization) Database
• USDA National Agricultural Statistics Service
• Global Trade Information Services (GTIS)
• Eurostat Agricultural Statistics
• Others

Magazines

• Poultry World Magazine
• WATT PoultryUSA
• Poultry International
• Egg Industry Magazine
• Others

Journals

• Avian Diseases Journal
• Poultry Science Journal
• Veterinary Microbiology Journal
• Others

Newspapers

• The Poultry Site
• Feedstuffs
• Agri-Pulse
• Farm Journal
• Others

Associations

• International Association of Poultry Processors (IAPP)
• World Poultry Science Association (WPSA)
• American Association of Avian Pathologists (AAAP)
• European Association of Poultry Processors and Poultry Trade (AVEC)
• Others

Public Domain Sources

• World Health Organization (WHO) Reports
• Centers for Disease Control and Prevention (CDC)
• European Food Safety Authority (EFSA)
• Government Agricultural Department Publications
• Others

Proprietary Elements

• CMI Data Analytics Tool
• Proprietary CMI Existing Repository of information for last 8 years